CN115551482A - 用于抑制和治疗冠状病毒感染的银纳米颗粒 - Google Patents

用于抑制和治疗冠状病毒感染的银纳米颗粒 Download PDF

Info

Publication number
CN115551482A
CN115551482A CN202180034838.0A CN202180034838A CN115551482A CN 115551482 A CN115551482 A CN 115551482A CN 202180034838 A CN202180034838 A CN 202180034838A CN 115551482 A CN115551482 A CN 115551482A
Authority
CN
China
Prior art keywords
silver nanoparticles
suspension
use according
infection
preferred embodiments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180034838.0A
Other languages
English (en)
Chinese (zh)
Inventor
安基特·阿加瓦尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN115551482A publication Critical patent/CN115551482A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202180034838.0A 2020-04-06 2021-04-06 用于抑制和治疗冠状病毒感染的银纳米颗粒 Pending CN115551482A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063005727P 2020-04-06 2020-04-06
US63/005,727 2020-04-06
PCT/US2021/025942 WO2021207178A1 (en) 2020-04-06 2021-04-06 Silver nanoparticles for use in inhibiting and treating coronavirus infection

Publications (1)

Publication Number Publication Date
CN115551482A true CN115551482A (zh) 2022-12-30

Family

ID=78023543

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180034838.0A Pending CN115551482A (zh) 2020-04-06 2021-04-06 用于抑制和治疗冠状病毒感染的银纳米颗粒

Country Status (5)

Country Link
US (1) US20230158067A1 (https=)
EP (1) EP4132467A4 (https=)
JP (1) JP2023521150A (https=)
CN (1) CN115551482A (https=)
WO (1) WO2021207178A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250338852A1 (en) * 2022-05-30 2025-11-06 Shin-Etsu Chemical Co., Ltd. Antiviral composition and member having same on surface

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050061678A1 (en) * 1999-06-01 2005-03-24 American Biotech Labs Treatment of humans with colloidal silver composition
KR20050077887A (ko) * 2004-01-28 2005-08-04 (주)지피엔이 코로나 바이러스 및 인플루엔자 바이러스 등에 억제능이있는 나노무기항균제
CN1859919A (zh) * 2003-10-16 2006-11-08 东亚合成株式会社 抗冠状病毒剂
CN102579490A (zh) * 2012-02-22 2012-07-18 大连大学 一种纳米银抗病毒溶液及其制作方法
CN102861102A (zh) * 2012-09-21 2013-01-09 华绣科技有限公司 一种纳米银抑菌喷剂
CN105412379A (zh) * 2015-12-09 2016-03-23 刘传新 一种吸入式治疗肺结核制剂及其制备方法
US20180368417A1 (en) * 2014-09-23 2018-12-27 Attostat, Inc. Antimicrobial compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090191247A1 (en) * 2004-12-06 2009-07-30 Nanotechnologies, Inc Anti-Viral Uses Of Carbon And Metal Nanomaterial Compositions
US20130315972A1 (en) * 2012-05-24 2013-11-28 Agienic, Inc. Compositions and methods for antimicrobial metal nanoparticles
WO2012174466A2 (en) * 2011-06-17 2012-12-20 Annuary Healthcare, Inc. Nanoscale particle formulations and methods
WO2016161348A1 (en) * 2015-04-01 2016-10-06 Attostat, Inc. Nanoparticle compositions and methods for treating or preventing tissue infections and diseases
SI25804A (sl) * 2020-03-19 2020-09-30 Danijela Marković Koloidno srebro za uporabo in postopek njegove priprave

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050061678A1 (en) * 1999-06-01 2005-03-24 American Biotech Labs Treatment of humans with colloidal silver composition
CN1859919A (zh) * 2003-10-16 2006-11-08 东亚合成株式会社 抗冠状病毒剂
KR20050077887A (ko) * 2004-01-28 2005-08-04 (주)지피엔이 코로나 바이러스 및 인플루엔자 바이러스 등에 억제능이있는 나노무기항균제
CN102579490A (zh) * 2012-02-22 2012-07-18 大连大学 一种纳米银抗病毒溶液及其制作方法
CN102861102A (zh) * 2012-09-21 2013-01-09 华绣科技有限公司 一种纳米银抑菌喷剂
US20180368417A1 (en) * 2014-09-23 2018-12-27 Attostat, Inc. Antimicrobial compositions and methods
CN105412379A (zh) * 2015-12-09 2016-03-23 刘传新 一种吸入式治疗肺结核制剂及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黄辛: "上海大学为抗击新冠肺炎研制纳米银病毒灭活喷雾", pages 3 - 4, Retrieved from the Internet <URL:https://news.sciencenet.cn/htmlnews/2020/2/436272.shtm> *

Also Published As

Publication number Publication date
US20230158067A1 (en) 2023-05-25
WO2021207178A1 (en) 2021-10-14
JP2023521150A (ja) 2023-05-23
EP4132467A1 (en) 2023-02-15
EP4132467A4 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
Pilaquinga et al. Silver nanoparticles as a potential treatment against SARS‐CoV‐2: A review
US8709496B2 (en) Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
CN101711761A (zh) 预防和治疗感冒和流感样症状的组合物和它们的使用方法
JP2023529022A (ja) コロナウイルス感染症の治療のための化合物
RU2339403C2 (ru) Композиции для профилактики и лечения симптомов, подобных симптомам простуды и гриппа, содержащие выбранные склеивающиеся со слизистой полимеры, и способы лечения
Liao et al. Inhaled dry powder formulation of tamibarotene, a broad‐spectrum antiviral against respiratory viruses including SARS‐CoV‐2 and influenza virus
CN115427076A (zh) 用于治疗冠状病毒感染的人去泛素化酶抑制剂
US20220096536A1 (en) THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
CN115551482A (zh) 用于抑制和治疗冠状病毒感染的银纳米颗粒
US11642372B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
CN103153315A (zh) 用吸入地纽福索治疗囊性纤维化的方法
US20220133786A1 (en) THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
HK40086332A (zh) 用於抑制和治疗冠状病毒感染的银纳米颗粒
US12042514B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
WO2023023647A2 (en) Compositions and methods for bimodal anti-viral combination therapy
TW201016215A (en) Compositions and uses of antiviral active pharmaceutical agents
WO2022046668A1 (en) Compositions and methods for reducing the transmissivity of illnesses
WO2021211923A1 (en) Compositions and methods for treating disease
CN102369012B (zh) 氧化氘用于治疗病毒性呼吸道疾病的用途
JP2023543352A (ja) 噴霧器および噴霧化された抗ウイルス薬
CN116033903A (zh) 奎宁及其产生先天免疫应答的用途
WO2020220855A1 (zh) 一种雾化吸入剂及其制备方法
US20220401472A1 (en) Compositions for prevention and treatment of rsv and coronavirus infection
AU2022410715B2 (en) Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2
HK40114977A (zh) 用於治疗冠状病毒感染的5-氨基-2，3-二氢-1，4-酞嗪二酮与6’-甲氧基辛可宁-9-醇的组合

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40086332

Country of ref document: HK